ANZON INC. – Trademark Portfolio

Entity Type: 03

ANZON INC. holds 19 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 19 filings in this category. Currently, 3 trademarks are registered. Notable registered marks include ONGARD, PYROBLOC, and MICROFINE. The owner is based in PHILADELPHIA, PA.

2545 ARAMINGO AVENUE

PHILADELPHIA, PA 19125

19 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

AZUB
AZUB
Cancelled 1997
TMS
TMS
Cancelled 1990
MICROFINE
MICROFINE
Registered 1986
FYREBLOC
FYREBLOC
Cancelled 1983
PYROBLOC
PYROBLOC
Registered 1983
TRUTINT
TRUTINT
Cancelled 1981
ONGARD
ONGARD
Registered 1975
XL
XL
Cancelled 1965
TRI-MAL
TRI-MAL
Cancelled 1951
DS-207
DS-207
Cancelled 1951
DYTHAL
DYTHAL
Cancelled 1951
DYPHOS
DYPHOS
Cancelled 1951

Trademark Classifications

ANZON INC.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (19 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does ANZON INC. have?

ANZON INC. has 19 U.S. trademarks filed with the USPTO. Of these, 3 registered, 16 cancelled.

What trademark classes does ANZON INC. file in?

ANZON INC. files trademarks across 1 Nice Classification class. The most active classes are Class 1 (Chemicals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are ANZON INC.'s most well-known trademarks?

ANZON INC.'s registered trademark portfolio includes well-known marks such as ONGARD, PYROBLOC, and MICROFINE. These are among 3 currently registered trademarks in the portfolio.

What is ANZON INC.'s trademark registration success rate?

ANZON INC. has a 16% trademark registration rate, with 3 out of 19 resolved applications resulting in successful registration. Currently, 0 applications are pending review.